Scipher Medicine Announces Investment By Optum Ventures Focused on Improving Patient Outcomes

Scipher Medicine Closes Series B Funding Led By Northpond Ventures

Defining response to TNF-inhibitors in rheumatoid arthritis: the negative impact of anti-TNF cycling

Scipher: Decoding Drug Response From Protein Interactions

Getting Personal With Precision Medicine

Bringing Precision Medicine to Autoimmune Diseases

How Precision Medicine Can Change the Drug Pricing Conversation

How A Blood Test Can Disrupt A $20B Market

Smart Medicine: AI plays an increasingly bigger role in health care

Deciphering RNA to Predict if a Patient Will Respond to a Targeted Drug

‘Response rate to top selling drugs is 10%’, says Scipher CEO

Scipher Medicine Builds Evidence for Tests Predicting Response to Autoimmune Disease Drugs